Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

What is Genetic Engineering?

What is Genetic Engineering?

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Advancements in development of novel class of HIV protease inhibitors.

Annals of medicine·2026

Same author

Host proteins interacting with integrase of human immunodeficiency virus type 1.

Biochemical pharmacology·2025

Same author

Newly approved integrase inhibitors for clinical treatment of AIDS.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2014

Same author

Virtual-screening targeting Human Immunodeficiency Virus type 1 integrase-lens epithelium-derived growth factor/p75 interaction for drug development.

Journal of drug targeting·2014

Same author

Discovery of a novel HIV-1 integrase inhibitor from natural compounds through structure based virtual screening and cell imaging.

FEBS letters·2014

Same author

Anti-HIV drug development through computational methods.

The AAPS journal·2014

Same journal

Engineering environmental bacteria for whole-cell PET hydrolysis and assimilation.

Trends in biotechnology·2026

Same journal

Acoustic cavitation-enhanced lymphatic trafficking of inhaled bacterial-sourced biohybrid vaccines for antitumor immunity.

Trends in biotechnology·2026

Same journal

Make uphill thermodynamics downhill in pathway design.

Trends in biotechnology·2026

Same journal

Engineering a capture-bioremediate-release microbial biofilm for simultaneous bioremediation of microplastics and adsorbed heavy metals.

Trends in biotechnology·2026

Same journal

Engineered bacterial biofilms for biotechnological applications.

Trends in biotechnology·2026

Same journal

Multiscale and programmable engineering of edible mushroom mycelium-based materials.

Trends in biotechnology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 18, 2026

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Genome editing-based HIV therapies.

¹Department of Immunology, Zunyi Medical University, Zunyi, Guizhou, 563000, China.

Trends in Biotechnology

|January 21, 2015

Summary

This summary is machine-generated.

Genome editing therapies aim to cure HIV by modifying genes like CCR5 to create resistant cells. A recent trial showed safety and efficacy, but long-term studies are needed for clinical use.

Keywords:

AIDS CCR5 HIV genome editing infusion

More Related Videos

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase

Published on: June 16, 2008

Related Experiment Videos

Last Updated: Apr 18, 2026

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase

Published on: June 16, 2008

Area of Science:

Biotechnology
Immunology
Infectious Diseases

Background:

HIV infection targets CD4(+) T cells.
Genome editing (GE) offers a potential strategy for HIV cure.
CCR5 is a key co-receptor for HIV entry and a target for GE therapies.

Purpose of the Study:

To evaluate the safety and efficacy of genome editing-based HIV therapy.
To explore the feasibility of using CCR5 as a target for HIV resistance.
To assess the potential for a functional or actual cure for HIV.

Main Methods:

Modification of infection-related genes, specifically CCR5, using genome editing techniques.
Production of autologous HIV-resistant CD4(+) T cells.
Reinfusion of modified cells into patients for therapeutic purposes.

Main Results:

A recent clinical trial demonstrated the safety and efficacy of infusing modified autologous CD4(+) T cells.
The CCR5 δ32 genotype naturally confers resistance to HIV, supporting CCR5 as a therapeutic target.
The study provided preliminary evidence for GE-based HIV therapy's potential.

Conclusions:

Genome editing targeting CCR5 is a promising approach for HIV therapy.
Current clinical evidence suggests safety and efficacy, but requires further long-term evaluation.
Long-term assessment is crucial before widespread clinical implementation of GE-based HIV therapy.